Oncology
Video - COPERNICUS, a pragmatic phase 2b Study of first-line subcutaneous amivantamab + lazertinib with supportive Care in EGFR-mutated advanced NSCLC: early safety results
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.